These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19524500)

  • 1. New hope for a microRNA therapy for liver cancer.
    Rossi JJ
    Cell; 2009 Jun; 137(6):990-2. PubMed ID: 19524500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
    Kota J; Chivukula RR; O'Donnell KA; Wentzel EA; Montgomery CL; Hwang HW; Chang TC; Vivekanandan P; Torbenson M; Clark KR; Mendell JR; Mendell JT
    Cell; 2009 Jun; 137(6):1005-17. PubMed ID: 19524505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [microRNA: new diagnostic and therapeutic tools in liver disease?].
    Gougelet A; Colnot S
    Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
    Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
    Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
    Borel F; Konstantinova P; Jansen PL
    J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc target miRs and liver cancer: small molecules to get Myc sick.
    Buendia MA; Bourre L; Cairo S
    Gastroenterology; 2012 Feb; 142(2):214-8. PubMed ID: 22178210
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasomics for Early Evaluation of the Tumor Response to MicroRNA-122 in a Nude Mouse Hepatocellular Carcinoma Model.
    Guo HL; Chen LD; Li W; Liang JY; Zhang JC; Li X; Xie XY; Lu MD; Kuang M; Wang W
    J Ultrasound Med; 2020 Jan; 39(1):61-71. PubMed ID: 31225651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene therapy of liver tumors].
    Panis Y; Charre L; Alves A; Soubrane O
    J Chir (Paris); 2000 Dec; 137(6):317-24. PubMed ID: 11119025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
    Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
    Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction and identification of the human liver-specific miR-122 expression vector].
    Huang Z; Liu C
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):587-90. PubMed ID: 19637636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.
    Sia KC; Huynh H; Chinnasamy N; Hui KM; Lam PY
    Gene Ther; 2012 May; 19(5):532-42. PubMed ID: 21918545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
    Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ
    Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes].
    Sun W; Tang Z; Wei D; Tang Y; Chen S
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
    Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy.
    Chen F
    Semin Cancer Biol; 2011 Feb; 21(1):1-3. PubMed ID: 21296670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.